207 related articles for article (PubMed ID: 2400987)
1. T47DCO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance.
Graham ML; Krett NL; Miller LA; Leslie KK; Gordon DF; Wood WM; Wei LL; Horwitz KB
Cancer Res; 1990 Oct; 50(19):6208-17. PubMed ID: 2400987
[TBL] [Abstract][Full Text] [Related]
2. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL
Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830
[TBL] [Abstract][Full Text] [Related]
3. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
Ghosh MG; Thompson DA; Weigel RJ
Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor mutations in tamoxifen-resistant breast cancer.
Karnik PS; Kulkarni S; Liu XP; Budd GT; Bukowski RM
Cancer Res; 1994 Jan; 54(2):349-53. PubMed ID: 8275466
[TBL] [Abstract][Full Text] [Related]
5. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
6. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer.
Zhang QX; Borg A; Fuqua SA
Cancer Res; 1993 Dec; 53(24):5882-4. PubMed ID: 8261397
[TBL] [Abstract][Full Text] [Related]
7. Variant human breast tumor estrogen receptor with constitutive transcriptional activity.
Fuqua SA; Fitzgerald SD; Chamness GC; Tandon AK; McDonnell DP; Nawaz Z; O'Malley BW; McGuire WL
Cancer Res; 1991 Jan; 51(1):105-9. PubMed ID: 1988075
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: analysis of breast cancer cell mixtures and genetic instability of the T47D line.
Graham ML; Dalquist KE; Horwitz KB
Cancer Res; 1989 Jul; 49(14):3943-9. PubMed ID: 2660983
[TBL] [Abstract][Full Text] [Related]
9. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
[TBL] [Abstract][Full Text] [Related]
10. Hormone-resistant breast cancer or "feeding the hand that bites you".
Horwitz KB
Prog Clin Biol Res; 1994; 387():29-45. PubMed ID: 7972253
[TBL] [Abstract][Full Text] [Related]
11. Altered phenotypic characteristics of T47d human breast cancer cells after prolonged growth in estrogen-deficient medium.
Fernandez P; Wilson C; Hoivik D; Safe SH
Cell Biol Int; 1998; 22(9-10):623-33. PubMed ID: 10452832
[TBL] [Abstract][Full Text] [Related]
12. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
Castles CG; Fuqua SA; Klotz DM; Hill SM
Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
[TBL] [Abstract][Full Text] [Related]
13. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
14. Binding analysis of the estrogen receptor to its specific DNA target site in human breast cancer.
Foster BD; Cavener DR; Parl FF
Cancer Res; 1991 Jul; 51(13):3405-10. PubMed ID: 2054780
[TBL] [Abstract][Full Text] [Related]
15. Acetaminophen-induced proliferation of breast cancer cells involves estrogen receptors.
Harnagea-Theophilus E; Gadd SL; Knight-Trent AH; DeGeorge GL; Miller MR
Toxicol Appl Pharmacol; 1999 Mar; 155(3):273-9. PubMed ID: 10079213
[TBL] [Abstract][Full Text] [Related]
16. Expression of estrogen receptor beta messenger RNA variant in breast cancer.
Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lupu R
Cancer Res; 1998 Jan; 58(2):210-4. PubMed ID: 9443393
[TBL] [Abstract][Full Text] [Related]
17. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
[TBL] [Abstract][Full Text] [Related]
18. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
19. An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer.
Zhang QX; Borg A; Wolf DM; Oesterreich S; Fuqua SA
Cancer Res; 1997 Apr; 57(7):1244-9. PubMed ID: 9102207
[TBL] [Abstract][Full Text] [Related]
20. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.
Saji S; Omoto Y; Shimizu C; Warner M; Hayashi Y; Horiguchi S; Watanabe T; Hayashi S; Gustafsson JA; Toi M
Cancer Res; 2002 Sep; 62(17):4849-53. PubMed ID: 12208729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
